• Published 18 Apr 2024

CatSci to Attend Anglonordic Life Science Conference 2024

  • Events

CatSci Ltd, an award-winning innovation partner for medicines development, will be attending the Anglonordic Life Science Conference 2024, taking place in County Hall London on 18th April 2024. 

Akil Jacobs Holden, our Business Development Executive, will be attending Anglonordic London. He is looking forward to networking with the industry and discussing how CatSci can address your CMC challenges with our in-depth drug development expertise. Our capabilities span from preclinical through all phases of development, commercialisation and post approval changes across process chemistryGMP-analyticalHPAPIsmaterial sciences and preformulation, and oligonucleotides. From candidate selection through product launch and beyond, CatSci can de-risk your pharmaceutical pipeline and accelerate your path to clinic. 

If you would like to book a meeting with Akil to discuss how we’ve helped companies with their route scouting, process design & optimisation and scale-up needs, get in touch here.    

Resources & Insights

  • 17 Mar 2026
CatSci Annual Sustainability Report 2025
  • Sustainability
  • News
  • 9 Mar 2026
  • Rob Crook
High Throughput Experimentation: Fully Integrated or Modular System?
  • Chemical Development
  • High Throughput Experimentation
  • Process R&D
  • Thought Leaders
  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders